生物制品板块1月23日涨1.45%，沃森生物领涨，主力资金净流入1.98亿元

Core Viewpoint - The biopharmaceutical sector experienced a rise of 1.45% on January 23, with Watson Bio leading the gains, while the Shanghai Composite Index increased by 0.33% and the Shenzhen Component Index rose by 0.79% [1]. Group 1: Biopharmaceutical Sector Performance - The closing price of Watson Bio was 12.99, with a gain of 6.30% and a trading volume of 1.0612 million shares, resulting in a transaction value of 1.364 billion [1]. - Other notable performers included Junshi Biosciences, which closed at 36.30 with a 3.42% increase, and Kangtai Biological, which closed at 15.97 with a 3.37% increase [1]. - The overall trading volume in the biopharmaceutical sector showed significant activity, with various companies experiencing notable price changes [1]. Group 2: Capital Flow Analysis - The biopharmaceutical sector saw a net inflow of 198 million in main funds, while retail funds experienced a net outflow of 272 million [2]. - The individual stock capital flow indicated that Watson Bio had a main fund net inflow of 1.34 billion, but also faced a retail net outflow of 50.32 million [3]. - Other companies like Changchun High-tech and Shanghai Laishi also showed mixed capital flows, with varying levels of net inflow and outflow from main and retail investors [3].